Beijing Kaiweisi Pharmaceutical Consulting

Beijing Kaiweisi Pharmaceutical Consulting, commonly known as KWS, is a leading Chinese contract research organization (CRO) providing comprehensive clinical development services to the pharmaceutical and biotechnology industries. Founded in 1997, the company specializes in clinical trial management, regulatory affairs, medical writing, and data management within the Chinese market. KWS was acquired by PPD (Pharmaceutical Product Development) in 2013 to strengthen its presence in the Asia-Pacific region, and it now operates as part of Thermo Fisher Scientific's clinical research business. The company is recognized for its expertise in navigating the complex regulatory landscape in China and supporting both domestic and international drug development programs. Its integration into a global network allows it to offer localized expertise backed by international standards.